NovaBridge is a global biotechnology platform company committed to accelerating access to innovative medicines. We combine deep business development expertise with agile translational clinical development to identify, accelerate, and advance breakthrough assets. By bridging science, strategy, and execution, NovaBridge enables transformative therapies to progress rapidly from discovery toward patients in need.

 

Mission

Bridging innovation and access to deliver transformational medicines for patients worldwide.

Values

• Innovation
• Execution
• Collaboration
• Passion

 

Our Business Model

NovaBridge partners with leading innovators to identify and accelerate high-value assets. Our model integrates rigorous asset selection, bespoke translational strategies, and world-class clinical execution. With the backing of CBC Group — Asia’s largest healthcare dedicated asset management firm — we leverage deep local insights and global capabilities to access the most promising drug candidates. We deliver tailored solutions for partners that unite global development expertise with on-the-ground knowledge. This approach ensures breakthrough therapies advance efficiently through clinical milestones and have the greatest chance of becoming transformational therapies.

 

Partners

ABio-X Logo
ablbio Logo
AskGene Pharma Logo
Everest Medecines Logo
TJ Biopharma Logo